News
-
GOCO comes back in 2021
It is difficult to forecast in the long term, and even in the short term, due to the current situation. Nevertheles, there is something clear, the determination of GOCO for retaking its activity in...
-
Cancellation GOCO 2020
Dear colleagues, Due to the current health situation with the COVID 19 coronavirus pandemic, the GOCO Board in conjunction with the Organising Committee of the 28th GOCO Congress have decided to...
-
XXVI GOCO Meeting
On November 16th, the XXVI Congress of Grup Oncologic Catala-Occita took place in Hospital del Mar of Barcelona. The participation was of 207 attendees, of whom 51 were physicians, 19 physicists, 69...
-
Erratum to “Voice quality after surgery or radiotherapy for glottic T1 squamous cell carcinoma: Results of the VOQUAL study” [Cancer Radiother. 28 (2024) 373–379]
Publication date: December 2024
Source: Cancer/Radiothérapie, Volume 28, Issue 8
Author(s): L. Jan, J. Labreuche, X. Liem, B. Rysman, M. Morisse, G. Mortuaire, F. Mouawad
-
Transformative clinical trials in gynaecologic radiation oncology in 2023–2024: Shaping modern treatment practices
Publication date: December 2024
Source: Cancer/Radiothérapie, Volume 28, Issue 8
Author(s): Zineb El Ayachi, Alexandra Gabro, Guillaume Camprodon, Supriya Chopra, Philippe
... -
Bronchiolite oblitérante avec organisation pneumonique secondaire à la radiothérapie : revue de la littérature et rapport de cas clinique
Publication date: December 2024
Source: Cancer/Radiothérapie, Volume 28, Issue 8
Author(s): Antoine Ailloud, Mael Morfin, Valérie Grangeon, Laurent Bertoletti, Jean-Philippe
... -
Safety of concurrent trastuzumab–emtansine and radiation therapy for breast cancer: Single-centre experience from a morbidity and mortality review meetings procedure
Publication date: December 2024
Source: Cancer/Radiothérapie, Volume 28, Issue 8
Author(s): Alexander Bennassi, Mohamed Aziz Chérif, Kamel Debbi, Yazid Belkacémi